Jiangsu HengRui Medicine Co., Ltd.: all 1,057 studies

Page 5 of 11. Open to participants first (303), then studies with results posted, then the rest; newest registration first within each.

• A Trial of HRS-9813 Capsule and Tablet in Healthy SubjectsCompletedNCT06939504Phase 1
• A Study to Evaluate the Safety, Tolerability and Dose-Response Relationship of HRS-9190 in Healthy SubjectsCompletedNCT06932315Phase 1
• A Phase 3 Clinical Study of SHR-A1912 Combined With R-GemOx Versus R-GemOx in Diffuse Large B-cell LymphomaActive, not recruitingNCT06929624Phase 3
• Relative Bioavailability Study of HR19042 in Healthy SubjectsCompletedNCT06922305Phase 1
• A Trial of HRS-7535 Tablets in Subjects With Overweight or ObesityCompletedNCT06904105Phase 3
• A Phase Ⅰ Clinical Trial to Evaluate the Safety, Tolerance, Pharmacokinetics and Pharmacodynamics of SHR-3045 in Healthy SubjectsCompletedNCT06883695Phase 1
• A Study Comparing HR17031 With Insulin Glargine in Patients With Type 2 DiabetesCompletedNCT06881264Phase 3
• A Mass Balance Study of [14C] SHR6508 in Chinese Hemodialysis Subjects With Secondary HyperparathyroidismCompletedNCT06877247Phase 1
• A Trial Comparing SHR-1139 Injection With Placebo in Patients With Moderate-to-severe Plaque PsoriasisActive, not recruitingNCT06875934Phase 2
• A Trial Comparing HR17031 With Insulin Glargine in Patients With Type 2 DiabetesCompletedNCT06871761Phase 3
• A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-1301 in Healthy SubjectsCompletedNCT06857253Phase 1
• Mass Balance Study of [14C]HRS9531 in Healthy Male SubjectsCompletedNCT06855147Phase 1
• A Trial of HRS-8427 in the Treatment of Adults With Bacterial PneumoniaCompletedNCT06841731Phase 2
• Efficacy and Safety of HRS9531 Tablet in Obese SubjectsCompletedNCT06841445Phase 2
• Study of SHR-1209 Administered by Single-site or Multiple-site Subcutaneous Injections in Healthy VolunteersCompletedNCT06837077Phase 1
• A Trial of HRS-5041-103 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-5041 in Subjects With Metastatic Castration-resistant Prostate CancerActive, not recruitingNCT06830850Phase 1
• A Clinical Study of SHR-2004 Injection in Preventing Venous Thromboembolism in Patients Undergoing Total Knee ArthroplastyCompletedNCT06825416Phase 3
• A Trial of HRS-9813 in Healthy SubjectsCompletedNCT06821464Phase 1
• A Clinical Study of Mass Balance of [14C]HRS-7535CompletedNCT06819488Phase 1
• A Study of HRS-5346 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular EventsCompletedNCT06816264Phase 2
• A Phase II Clinical Study of HRS-1893 in Non-obstructive Hypertrophic CardiomyopathyCompletedNCT06816251Phase 2
• The Evaluation of Bioequivalence Between a Single-dose Pen and a Multi-dose Pen of HRS9531 Injection SolutionCompletedNCT06792955Phase 1
• A Trial of SHR0302Base in Patients With VitiligoActive, not recruitingNCT06790862Phase 2
• Pharmacokinetics, Pharmacodynamics, Safety, and Preliminary Efficacy of Subcutaneous Injection of SHR-1905 in Adolescent Asthmatic Subjects - an Open-label, Single-dose Phase II Clinical StudyCompletedNCT06786455Phase 2
• Clinical Study of HRS-2129 for Postoperative Analgesia in OrthopaedicsCompletedNCT06780267Phase 1/2
• Safety and Pharmacokinetics Study of HRS-1893 Tablets in Healthy Subjects and Those With Impaired Kidney FunctionCompletedNCT06775834Phase 1
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-4729 Injection in Healthy SubjectsCompletedNCT06762600Phase 1
• A Multiple Ascending Dose Trial of HRS-2129 in Healthy SubjectsCompletedNCT06742840Phase 1
• A Phase I Clinical Study of a Single Subcutaneous Injection of HRS-5632 in Healthy SubjectsCompletedNCT06732154Phase 1
• Study on Drug Interaction of Metformin Tablets and HRS-7535 Tablets in Healthy HumanCompletedNCT06727838Phase 1
• Influence of HRS9531 on Gastric Emptying and Pharmacokinetics of Metformin, Atorvastatin, Warfarin, and Digoxin in Healthy SubjectsCompletedNCT06723691Phase 1
• A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial HypercholesterolemiaCompletedNCT06723652Phase 3
• Efficacy and Safety of HRS-5965 in Patients With PNH Who Are Still Anemia After Anti-C5 Antibody TreatmentCompletedNCT06715943Phase 3
• A Phase Ib/II Study to Investigate the Safety of SHR-1819 in Children and Adolescents With Moderate-to-severe Atopic DermatitisCompletedNCT06713499Phase 1/2
• Investigation of Drug-drug Interaction of Ritonavir and Itraconazole on the Pharmacokinetics of SHR-A1811 in Subjects With HER2-expressing Advanced Breast CancerCompletedNCT06710990Phase 1
• A Safety, Tolerability, Pharmacokinetic Study of SHR-6934 Injection in Healthy SubjectsCompletedNCT06700083Phase 1
• Efficacy and Safety of SHR-3167 and Insulin Glargine in Type 2 Diabetes SubjectsCompletedNCT06688123Phase 2
• A Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Study, and QT Interval Study of HRS-5965 Capsules in Healthy SubjectsCompletedNCT06684041Phase 1
• Investigation of Pharmacokinetics,Safety,and Pharmacodynamics of HRS-5965 in Subjects With Hepatic ImpairmentCompletedNCT06674915Phase 1
• A Study of HRS-7535 Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequately Controlled With Diet and ExerciseCompletedNCT06672172Phase 3
• Long-term Efficacy and Safety of HRS-7535 Tablets in Obese SubjectsCompletedNCT06671821Phase 2
• A Study of SHR-A2009 Versus Platinum-based Chemotherapy in EGFR-mutated, Advanced or Metastatic NSCLCActive, not recruitingNCT06671379Phase 3
• Pharmacokinetics, Dialysability and Safety of HRS-9231 in Healthy Volunteers and in Patients With Impaired Renal FunctionCompletedNCT06657560Phase 1
• Influence of HRS9531 on Pharmacokinetics of Metformin in Healthy SubjectsCompletedNCT06654960Phase 1
• A Multi-centered，Randomized，Double-blind，Placebo-controlled Study to Evaluate the Efficacy and Safety of SHR-1703 in Eosinophilic AsthmaActive, not recruitingNCT06653322Phase 3
• the Efficacy and Safety of HRS9531 Injection in Subjects With Type 2 Diabetes， Inadequately Controlled With Diet and Exercise AloneCompletedNCT06650007Phase 3
• The Experiment of Noiiglutide Injection in Type 2 Diabetes PatientsCompletedNCT06649773Phase 3
• A Study of HRS9531 Versus Semaglutide Once Weekly as Add-on Therapy to Metformin Monotherapy or in Combination With SGLT2 Inhibitors in Participants With Type 2 DiabetesCompletedNCT06649344Phase 3
• A Study of the Efficacy and Safety of SHR-1314 for Adult Active Psoriatic ArthritisActive, not recruitingNCT06640257Phase 3
• A Study of Safety and Tolerability of Multiple Doses of HRS-7535 in Obese SubjectsCompletedNCT06621316Phase 1/2
• A Clinical Study to Evaluate the Relative Bioavailability and Food Effect of HRS-8080 in Healthy SubjectsCompletedNCT06619873Phase 1
• A Single Dose Escalation Trial of HRS-2129 in Healthy SubjectsCompletedNCT06619392Phase 1
• Pharmacokinetics,Pharmacodynamics,Efficacy and Safety of HRG2010 in Parkinson's Disease Patients With Motor FluctuationsCompletedNCT06614153Phase 2
• A Study to Evaluate the Efficacy and Safety of HRG2010 in Parkinson's Disease With Motor FluctuationsCompletedNCT06596876Phase 3
• A Multicenter, Randomized, Double-blind, Placebo-parallel-controlled Phase II Clinical Study Evaluating the Efficacy and Safety of HRS9531 Injection in Obese Subjects With Polycystic Ovary SyndromeStatus unknownNCT06595797Phase 2
• A Study to Evaluate the Efficacy and Safety of Oral HRS-5965 in Adult Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Who Are Naive to Complement Inhibitor TherapyCompletedNCT06593938Phase 3
• A Study of HRS-7535 Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequately Controlled With MetforminCompletedNCT06589765Phase 3
• A Trial of HRS-8427 in the Treatment of Adults With Complicated Urinary Tract Infection, Including Acute PyelonephritisCompletedNCT06569056Phase 3
• A Study to Evaluate the Mass Balance of [14C] HRS-5965 in Healthy Adult Male VolunteersCompletedNCT06567392Phase 1
• A Trial of SHR-4602 Infusion in Patients With SHR-4602 in Subjects With HER2-expressing or HER2-mutated Locally Advanced or Metastatic Solid TumorsWithdrawnNCT06560138Phase 1
• Phase 1 Study to Evaluate PK, Safety, and Tolerability of HRS-5041 in Healthy Caucasian Male ParticipantsCompletedNCT06559007Phase 1
• HR20013 for Nausea and Vomiting Associated With Moderate Emetic Risk Anticancer AgentsCompletedNCT06554184Phase 3
• A Study on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-7249 Injection in Healthy SubjectsCompletedNCT06541457Phase 1
• Phase 1 Study of HRS-9231 Safety and Pharmacokinetics in Healthy CaucasiansCompletedNCT06519981Early Phase 1
• SHR-4602 for Injection in Subjects With HER2-expressing or -Mutated Unresectable or Metastatic Solid TumorsTerminatedNCT06516926Phase 2
• A Trial of HRS-1893 in Patients With Obstructive Hypertrophic CardiomyopathyActive, not recruitingNCT06516068Phase 2
• A Trial of HRS-9813 in Healthy VolunteersCompletedNCT06514963Phase 1
• Phase Ⅱ Study of Adductor Canal Block With HR18034 for Postsurgical Pain Management in TKATerminatedNCT06509958Phase 2
• The Phase III Clinical Study of Herombopag for the Treatment of Thrombocytopenia in Chronic Liver Disease Patients Undergoing Elective Invasive SurgeryCompletedNCT06507436Phase 3
• A Study of HRS-9057 in Patients With Heart Failure and Volume OverloadCompletedNCT06506994Phase 1
• Study on Drug Interaction of HRS-1780 Tablets, Henagliflozin Tablets, Metformin Tablets and HRS-7535 Tablets in Healthy HumanCompletedNCT06495931Phase 1
• Comparison of HRS-5965 Capsules and Tablets in Healthy SubjectsCompletedNCT06490991Phase 1
• A Trial of HRS5580 in Prevention of Postoperative Nausea and Vomiting of AdultsCompletedNCT06475846Phase 2
• Efficacy and Safety of SHR-1918 in Patients With HyperlipidemiaCompletedNCT06471218Phase 2
• Efficacy and Safety Study of SHR-1819 Injection in Adult Patients With Severe Atopic DermatitisCompletedNCT06468956Phase 3
• SHR-8068 in Combination With Adebrelimab, Bevacizumab, and Platinum-Based Chemotherapy as First-line Treatment in Patients With Advanced Biliary Tract CancerActive, not recruitingNCT06465563Phase 2
• Safety, Tolerability, and Preliminary Efficacy of HRS-7450 Injection in the Treatment of Acute Ischemic Stroke: a Multi-center, Randomized, Double-blind, Double-dummy, Placebo-controlled Clinical TrialCompletedNCT06447415Phase 1
• Safety and Tolerance of Increased Doses of HRS-5346 Tablets in Healthy SubjectsCompletedNCT06441227Phase 1
• A Study of Single and Multiple Doses HRS9531 Tablets in Healthy SubjectsCompletedNCT06435676Phase 1
• The Trial of SHR6508 in Secondary HyperparathyroidismCompletedNCT06434961Phase 3
• Clinical Study of SHR-A1921 Combined With Adebrelimab and SHR-8068 With or Without Carboplatin in the Treatment of Advanced NSCLCWithdrawnNCT06434103Phase 1/2
• Bioavailability and Food Effects of HRS-7535 Tablets With Different Formulating Processes in Healthy SubjectsCompletedNCT06422039Phase 1
• Efficacy and Safety of HRS-7535 Tablets in Adults With Diabetic Kidney Disease in Type 2 DiabetesCompletedNCT06415214Phase 2
• Clinical Trial of HR091506 Tablets in Treatment of Gout With Hyperuricemia in AdultsStatus unknownNCT06414837Phase 3
• Phase II Clinical Study of SHR-A1811 in Patients With HER2 Expression / Amplification of Locally Advanced Unresectable or Recurrent Metastatic Biliary Tract CancerActive, not recruitingNCT06413745Phase 2
• A Study to Evaluate the Mass Balance of [14C]SHR7280 in Healthy Adult VolunteersCompletedNCT06408948Phase 1
• To Compare the Efficacy and Safety of HRS9531 and Placebo in Subjects With Overweight or ObeseCompletedNCT06396429Phase 3
• Efficacy and Safety of HRS-7535 Tablets in T2DM Subjects Poorly Controlled With Metformin and SGLT2i.CompletedNCT06393348Phase 2
• HRS9531 Injection in Obese Subjects With Heart Failure With Preserved Ejection FractionActive, not recruitingNCT06391710Phase 2
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SHR-4597 Inhalation in Healthy Subjects and Asthmatic PatientsCompletedNCT06385964Phase 1
• A Study of HRS-4642 in Patients With Advanced Solid Tumors Harboring KRAS G12D MutationActive, not recruitingNCT06385678Phase 1/2
• The Clinical Study of SHR-7631 for Injection in Patients With Advanced Solid TumorsCompletedNCT06381050Phase 1
• PK/PD Study of SHR-2017 Injection in Patients With Bone MetastasesCompletedNCT06380881Phase 1
• Effect of Verapamil Tablets on the Pharmacokinetic of HRS-1893 Tablets in Healthy SubjectsCompletedNCT06354556Phase 1
• Randomized, Double-blind, Placebo-controlled Study of RSS0393 Ointment in Healthy and Psoriatic SubjectsActive, not recruitingNCT06308393Phase 1
• Study on the Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-2004 Injection in Adult Patients With Atrial FibrillationCompletedNCT06280768Phase 1
• A Trial of HHPG-19K Injection and Auto-HHPG-19K Injection in Prevention of Chemotherapy-related Moderate to Severe Neutropenia of Patients With Nonmyeloid MalignanciesWithdrawnNCT06254742Phase 3
• Efficacy and Safety of HRS-7535 Tablets in Obese Subjects .CompletedNCT06250946Phase 2
• Study of SHR-8068 Combined With Adebrelimab and Platinum-containing Chemotherapy in the Treatment of Advanced Gastric and Esophageal CancerActive, not recruitingNCT06247956Phase 2
• A Study of HRS9531 in Participants With Impaired Kidney Function and Healthy SubjectsCompletedNCT06246175Phase 1

← Jiangsu HengRui Medicine Co., Ltd. overview and focus areas